

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.74468629 |
| 2 | hemidesmosome assembly (GO:0031581) | 4.17989011 |
| 3 | multicellular organismal water homeostasis (GO:0050891) | 4.01305511 |
| 4 | establishment of skin barrier (GO:0061436) | 3.96847191 |
| 5 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.92534863 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 3.79312752 |
| 7 | establishment of apical/basal cell polarity (GO:0035089) | 3.79128264 |
| 8 | desmosome organization (GO:0002934) | 3.78454562 |
| 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.75655683 |
| 10 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.67737706 |
| 11 | regulation of gene silencing by miRNA (GO:0060964) | 3.67737706 |
| 12 | regulation of gene silencing by RNA (GO:0060966) | 3.67737706 |
| 13 | primary alcohol catabolic process (GO:0034310) | 3.62857902 |
| 14 | cysteine metabolic process (GO:0006534) | 3.58199679 |
| 15 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.57664532 |
| 16 | surfactant homeostasis (GO:0043129) | 3.54183179 |
| 17 | interferon-gamma secretion (GO:0072643) | 3.52476249 |
| 18 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.47117668 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.43335306 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 3.43335306 |
| 21 | bile acid and bile salt transport (GO:0015721) | 3.42925311 |
| 22 | water homeostasis (GO:0030104) | 3.36918669 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 3.27710479 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.27710479 |
| 25 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.25371581 |
| 26 | transcytosis (GO:0045056) | 3.20658550 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.19875489 |
| 28 | Golgi transport vesicle coating (GO:0048200) | 3.19632970 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.19632970 |
| 30 | intestinal epithelial cell development (GO:0060576) | 3.19406819 |
| 31 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.14868741 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 3.12294626 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 3.11887150 |
| 34 | reverse cholesterol transport (GO:0043691) | 3.10393022 |
| 35 | vitamin transmembrane transport (GO:0035461) | 3.08967227 |
| 36 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08404356 |
| 37 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08404356 |
| 38 | ethanol metabolic process (GO:0006067) | 3.06875340 |
| 39 | aromatic amino acid family catabolic process (GO:0009074) | 3.05222351 |
| 40 | protein carboxylation (GO:0018214) | 3.04694656 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.04694656 |
| 42 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.03786686 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02325297 |
| 44 | homocysteine metabolic process (GO:0050667) | 3.01765991 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 3.01267825 |
| 46 | urea metabolic process (GO:0019627) | 3.00997527 |
| 47 | urea cycle (GO:0000050) | 3.00997527 |
| 48 | glyoxylate metabolic process (GO:0046487) | 2.99099035 |
| 49 | proline biosynthetic process (GO:0006561) | 2.99068369 |
| 50 | endothelium development (GO:0003158) | 2.97797984 |
| 51 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.96961126 |
| 52 | NADPH regeneration (GO:0006740) | 2.95663783 |
| 53 | drug catabolic process (GO:0042737) | 2.94717679 |
| 54 | peptide catabolic process (GO:0043171) | 2.93809141 |
| 55 | response to nitrosative stress (GO:0051409) | 2.92373855 |
| 56 | regulation of protein activation cascade (GO:2000257) | 2.92194518 |
| 57 | * tight junction assembly (GO:0070830) | 2.90980685 |
| 58 | flavonoid metabolic process (GO:0009812) | 2.90660589 |
| 59 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.89282386 |
| 60 | tryptophan catabolic process (GO:0006569) | 2.89253555 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 2.89253555 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 2.89253555 |
| 63 | negative regulation of cell fate specification (GO:0009996) | 2.88971220 |
| 64 | basement membrane organization (GO:0071711) | 2.88305215 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 2.88082108 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 2.87775620 |
| 67 | tryptophan metabolic process (GO:0006568) | 2.87297448 |
| 68 | xenobiotic catabolic process (GO:0042178) | 2.84948721 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 2.84329725 |
| 70 | vitamin transport (GO:0051180) | 2.82327891 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.82106775 |
| 72 | urate metabolic process (GO:0046415) | 2.80556188 |
| 73 | regulation of complement activation (GO:0030449) | 2.80459548 |
| 74 | regulation of cardioblast differentiation (GO:0051890) | 2.80394667 |
| 75 | kynurenine metabolic process (GO:0070189) | 2.79742137 |
| 76 | phospholipid efflux (GO:0033700) | 2.79462925 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 2.78051007 |
| 78 | polarized epithelial cell differentiation (GO:0030859) | 2.77975131 |
| 79 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77657846 |
| 80 | pentose-phosphate shunt (GO:0006098) | 2.77494892 |
| 81 | cholesterol homeostasis (GO:0042632) | 2.77169103 |
| 82 | epithelial cell-cell adhesion (GO:0090136) | 2.76530521 |
| 83 | sterol homeostasis (GO:0055092) | 2.76406856 |
| 84 | complement activation, alternative pathway (GO:0006957) | 2.75437107 |
| 85 | pre-miRNA processing (GO:0031054) | 2.74679701 |
| 86 | triglyceride homeostasis (GO:0070328) | 2.74429012 |
| 87 | acylglycerol homeostasis (GO:0055090) | 2.74429012 |
| 88 | proline metabolic process (GO:0006560) | 2.74321940 |
| 89 | amyloid precursor protein catabolic process (GO:0042987) | 2.73959597 |
| 90 | histone H3-K36 demethylation (GO:0070544) | 2.73158011 |
| 91 | renal absorption (GO:0070293) | 2.72374231 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 2.71744795 |
| 93 | alpha-linolenic acid metabolic process (GO:0036109) | 2.71696392 |
| 94 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.69656168 |
| 95 | regulation of fibrinolysis (GO:0051917) | 2.69519891 |
| 96 | phospholipid homeostasis (GO:0055091) | 2.69344334 |
| 97 | trophectodermal cell differentiation (GO:0001829) | 2.69086888 |
| 98 | protein autoprocessing (GO:0016540) | 2.68773605 |
| 99 | protein complex localization (GO:0031503) | 2.67333616 |
| 100 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.66913863 |
| 101 | lysine catabolic process (GO:0006554) | 2.65335360 |
| 102 | lysine metabolic process (GO:0006553) | 2.65335360 |
| 103 | gap junction assembly (GO:0016264) | 2.64644179 |
| 104 | polyketide metabolic process (GO:0030638) | 2.64635744 |
| 105 | doxorubicin metabolic process (GO:0044598) | 2.64635744 |
| 106 | daunorubicin metabolic process (GO:0044597) | 2.64635744 |
| 107 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.62967727 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 2.62611057 |
| 109 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.60769511 |
| 110 | establishment of monopolar cell polarity (GO:0061162) | 2.60769511 |
| 111 | glucuronate metabolic process (GO:0019585) | 2.60761080 |
| 112 | uronic acid metabolic process (GO:0006063) | 2.60761080 |
| 113 | embryonic process involved in female pregnancy (GO:0060136) | 2.60638155 |
| 114 | regulation of cell fate specification (GO:0042659) | 2.58859857 |
| 115 | glycine metabolic process (GO:0006544) | 2.58693950 |
| 116 | regulation of water loss via skin (GO:0033561) | 2.57975084 |
| 117 | chemical homeostasis within a tissue (GO:0048875) | 2.57957803 |
| 118 | keratinocyte proliferation (GO:0043616) | 2.57570496 |
| 119 | negative regulation of sterol transport (GO:0032372) | 2.57421546 |
| 120 | negative regulation of cholesterol transport (GO:0032375) | 2.57421546 |
| 121 | pantothenate metabolic process (GO:0015939) | 2.57122194 |
| 122 | L-ascorbic acid metabolic process (GO:0019852) | 2.56316791 |
| 123 | lipoprotein metabolic process (GO:0042157) | 2.54590264 |
| 124 | regulation of transforming growth factor beta production (GO:0071634) | 2.54384312 |
| 125 | fibrinolysis (GO:0042730) | 2.54279132 |
| 126 | biotin metabolic process (GO:0006768) | 2.53698555 |
| 127 | bile acid biosynthetic process (GO:0006699) | 2.53069304 |
| 128 | bile acid metabolic process (GO:0008206) | 2.52400065 |
| 129 | * cell-cell junction assembly (GO:0007043) | 2.51994019 |
| 130 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.51960331 |
| 131 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.51496693 |
| 132 | axonemal dynein complex assembly (GO:0070286) | 2.50989472 |
| 133 | cellular glucuronidation (GO:0052695) | 2.50491653 |
| 134 | exogenous drug catabolic process (GO:0042738) | 2.50176422 |
| 135 | regulation of cholesterol esterification (GO:0010872) | 2.49415220 |
| 136 | regulation of lipoprotein particle clearance (GO:0010984) | 2.48922828 |
| 137 | regulation of keratinocyte differentiation (GO:0045616) | 2.48668574 |
| 138 | glomerular epithelial cell development (GO:0072310) | 2.47647866 |
| 139 | carnitine metabolic process (GO:0009437) | 2.47332712 |
| 140 | O-glycan processing (GO:0016266) | 2.47276747 |
| 141 | regulation of keratinocyte proliferation (GO:0010837) | 2.45251059 |
| 142 | intestinal absorption (GO:0050892) | 2.45229926 |
| 143 | cell-substrate junction assembly (GO:0007044) | 2.44459085 |
| 144 | drug metabolic process (GO:0017144) | 2.44179516 |
| 145 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.44061131 |
| 146 | hormone catabolic process (GO:0042447) | 2.43666864 |
| 147 | negative regulation of lipase activity (GO:0060192) | 2.42938141 |
| 148 | plasma lipoprotein particle clearance (GO:0034381) | 2.42394276 |
| 149 | sodium-independent organic anion transport (GO:0043252) | 2.41256317 |
| 150 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.41028232 |
| 151 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.40733728 |
| 152 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.40733728 |
| 153 | diterpenoid biosynthetic process (GO:0016102) | 2.40123535 |
| 154 | aromatic amino acid family metabolic process (GO:0009072) | 2.39702170 |
| 155 | serine family amino acid metabolic process (GO:0009069) | 2.39015904 |
| 156 | ethanol oxidation (GO:0006069) | 2.38889969 |
| 157 | glucose catabolic process (GO:0006007) | 2.38544996 |
| 158 | fatty acid beta-oxidation (GO:0006635) | 2.38434885 |
| 159 | protein-lipid complex assembly (GO:0065005) | 2.38086021 |
| 160 | acute-phase response (GO:0006953) | 2.37534637 |
| 161 | arginine metabolic process (GO:0006525) | 2.36942789 |
| 162 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.36685726 |
| 163 | fatty acid oxidation (GO:0019395) | 2.36559848 |
| 164 | epoxygenase P450 pathway (GO:0019373) | 2.36347843 |
| 165 | sphingomyelin metabolic process (GO:0006684) | 2.36262270 |
| 166 | keratinocyte development (GO:0003334) | 2.36170145 |
| 167 | amyloid precursor protein metabolic process (GO:0042982) | 2.35287947 |
| 168 | iron ion import (GO:0097286) | 2.34524375 |
| 169 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.33102976 |
| 170 | regulation of apoptotic cell clearance (GO:2000425) | 2.30980631 |
| 171 | negative regulation of cell fate commitment (GO:0010454) | 2.27141012 |
| 172 | paraxial mesoderm development (GO:0048339) | 2.26010197 |
| 173 | toxin transport (GO:1901998) | 2.25023910 |
| 174 | nodal signaling pathway (GO:0038092) | 2.24418620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.67594140 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.47212135 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.11936083 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.91423540 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85225963 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.83162574 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36741391 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87462836 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.81799684 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.75087312 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56073390 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.42268702 |
| 13 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.40948633 |
| 14 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40353435 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.40067352 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36688401 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11752781 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10826372 |
| 19 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.06071066 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01746825 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92924461 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92452819 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92285344 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.90625451 |
| 25 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.89866170 |
| 26 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.87474818 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80718077 |
| 28 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.77868249 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.75625369 |
| 30 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.74897290 |
| 31 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.71402437 |
| 32 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67688292 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.67227166 |
| 34 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.66170209 |
| 35 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.66170209 |
| 36 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.66170209 |
| 37 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.62965138 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60620886 |
| 39 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.53209966 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52881410 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52599872 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52389887 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.49948164 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46142012 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43270551 |
| 46 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.42173833 |
| 47 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.40697916 |
| 48 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.40697916 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39631501 |
| 50 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.39163892 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38571969 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38387247 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36937723 |
| 54 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36663061 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35498721 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34522948 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33037785 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32478920 |
| 59 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.31357230 |
| 60 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.30839649 |
| 61 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30066804 |
| 62 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24929263 |
| 63 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.22371392 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.20759946 |
| 65 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.19178772 |
| 66 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18616944 |
| 67 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16367260 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14855818 |
| 69 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14801286 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12877880 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12402105 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12032871 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11632092 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11572402 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11395953 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11312975 |
| 77 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.11152479 |
| 78 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10278571 |
| 79 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.08623998 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08491900 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08175487 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07268023 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06616910 |
| 84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04860468 |
| 85 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.04029326 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03343116 |
| 87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03319986 |
| 88 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02424878 |
| 89 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.01977069 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01285344 |
| 91 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00961253 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00452438 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99640148 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99471514 |
| 95 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96486363 |
| 96 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.92997874 |
| 97 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.92432050 |
| 98 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92051916 |
| 99 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91973006 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91780525 |
| 101 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.90417081 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90296608 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89657201 |
| 104 | MYC_22102868_ChIP-Seq_BL_Human | 0.89374857 |
| 105 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89122463 |
| 106 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.88285964 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88201227 |
| 108 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87801803 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87767165 |
| 110 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87041747 |
| 111 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85641934 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85634433 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83446179 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82308513 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79726913 |
| 116 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.78433113 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78199089 |
| 118 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.75310150 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75039113 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74817636 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74817636 |
| 122 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.74424967 |
| 123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72100475 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72050733 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.71882256 |
| 126 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.71070307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.68840285 |
| 2 | MP0005360_urolithiasis | 3.62756506 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.50003378 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.10116171 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.09325271 |
| 6 | MP0005365_abnormal_bile_salt | 2.90991353 |
| 7 | MP0009840_abnormal_foam_cell | 2.67879589 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45877155 |
| 9 | MP0003252_abnormal_bile_duct | 2.42778582 |
| 10 | MP0002254_reproductive_system_inflammat | 2.38772179 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.28155725 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.08712714 |
| 13 | MP0000579_abnormal_nail_morphology | 2.06869474 |
| 14 | MP0008004_abnormal_stomach_pH | 2.05362667 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.05059830 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.02177693 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 1.98699715 |
| 18 | MP0002796_impaired_skin_barrier | 1.96289295 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.95254380 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.89265724 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 1.88129748 |
| 22 | MP0003878_abnormal_ear_physiology | 1.88129748 |
| 23 | MP0003941_abnormal_skin_development | 1.84175555 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.81787950 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.74786273 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.63787728 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.61113734 |
| 28 | MP0004272_abnormal_basement_membrane | 1.59075290 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.57982908 |
| 30 | MP0001879_abnormal_lymphatic_vessel | 1.57107218 |
| 31 | MP0005083_abnormal_biliary_tract | 1.51189234 |
| 32 | MP0002098_abnormal_vibrissa_morphology | 1.49788578 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.49386395 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.45753232 |
| 35 | MP0005332_abnormal_amino_acid | 1.45104164 |
| 36 | MP0010678_abnormal_skin_adnexa | 1.43960684 |
| 37 | MP0006054_spinal_hemorrhage | 1.42667453 |
| 38 | MP0000467_abnormal_esophagus_morphology | 1.37889799 |
| 39 | MP0000609_abnormal_liver_physiology | 1.37424160 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.36344567 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.30813150 |
| 42 | MP0008260_abnormal_autophagy | 1.26679053 |
| 43 | MP0003724_increased_susceptibility_to | 1.22647818 |
| 44 | MP0000383_abnormal_hair_follicle | 1.21913407 |
| 45 | MP0003195_calcinosis | 1.19038931 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.18216991 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.17370002 |
| 48 | MP0001730_embryonic_growth_arrest | 1.16990305 |
| 49 | MP0000858_altered_metastatic_potential | 1.16386874 |
| 50 | MP0005409_darkened_coat_color | 1.16385523 |
| 51 | MP0009053_abnormal_anal_canal | 1.13576924 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.13155065 |
| 53 | MP0001756_abnormal_urination | 1.12915163 |
| 54 | MP0001216_abnormal_epidermal_layer | 1.12431143 |
| 55 | MP0003828_pulmonary_edema | 1.09612847 |
| 56 | MP0005501_abnormal_skin_physiology | 1.09378672 |
| 57 | MP0009672_abnormal_birth_weight | 1.08035357 |
| 58 | MP0000490_abnormal_crypts_of | 1.05979563 |
| 59 | MP0000537_abnormal_urethra_morphology | 1.05293416 |
| 60 | MP0003303_peritoneal_inflammation | 1.05283358 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.04377536 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.03990808 |
| 63 | MP0001849_ear_inflammation | 1.01270741 |
| 64 | MP0005023_abnormal_wound_healing | 1.01131948 |
| 65 | MP0010771_integument_phenotype | 0.98919648 |
| 66 | MP0009931_abnormal_skin_appearance | 0.98590131 |
| 67 | MP0002060_abnormal_skin_morphology | 0.97937679 |
| 68 | MP0003890_abnormal_embryonic-extraembry | 0.97246079 |
| 69 | MP0003186_abnormal_redox_activity | 0.96216232 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.95584610 |
| 71 | MP0002136_abnormal_kidney_physiology | 0.93917882 |
| 72 | MP0005647_abnormal_sex_gland | 0.91812499 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.90165793 |
| 74 | MP0002132_abnormal_respiratory_system | 0.87867897 |
| 75 | MP0004947_skin_inflammation | 0.87505135 |
| 76 | MP0003984_embryonic_growth_retardation | 0.87403175 |
| 77 | MP0005380_embryogenesis_phenotype | 0.87279501 |
| 78 | MP0001672_abnormal_embryogenesis/_devel | 0.87279501 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.87199291 |
| 80 | MP0005275_abnormal_skin_tensile | 0.85895189 |
| 81 | MP0005670_abnormal_white_adipose | 0.85203167 |
| 82 | MP0000598_abnormal_liver_morphology | 0.85164721 |
| 83 | MP0003718_maternal_effect | 0.84834263 |
| 84 | MP0006138_congestive_heart_failure | 0.84818357 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.84245844 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.83564727 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.80300443 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.79919468 |
| 89 | MP0001542_abnormal_bone_strength | 0.78640331 |
| 90 | MP0001881_abnormal_mammary_gland | 0.77985271 |
| 91 | MP0001764_abnormal_homeostasis | 0.77043939 |
| 92 | MP0002089_abnormal_postnatal_growth/wei | 0.75151828 |
| 93 | MP0001853_heart_inflammation | 0.74218037 |
| 94 | MP0000627_abnormal_mammary_gland | 0.73034850 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.72907317 |
| 96 | MP0008469_abnormal_protein_level | 0.72904257 |
| 97 | MP0006082_CNS_inflammation | 0.72222557 |
| 98 | MP0000377_abnormal_hair_follicle | 0.72152200 |
| 99 | MP0002084_abnormal_developmental_patter | 0.72017137 |
| 100 | MP0009764_decreased_sensitivity_to | 0.71109583 |
| 101 | MP0001851_eye_inflammation | 0.70835516 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 0.70757703 |
| 103 | MP0005395_other_phenotype | 0.70078984 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.69645800 |
| 105 | MP0005165_increased_susceptibility_to | 0.69513372 |
| 106 | MP0000343_altered_response_to | 0.68516314 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.67593856 |
| 108 | MP0001765_abnormal_ion_homeostasis | 0.67563643 |
| 109 | * MP0002080_prenatal_lethality | 0.67452126 |
| 110 | MP0003868_abnormal_feces_composition | 0.67373928 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.66817862 |
| 112 | MP0000516_abnormal_urinary_system | 0.64412459 |
| 113 | MP0005367_renal/urinary_system_phenotyp | 0.64412459 |
| 114 | MP0000249_abnormal_blood_vessel | 0.64278472 |
| 115 | MP0005408_hypopigmentation | 0.63205030 |
| 116 | MP0001697_abnormal_embryo_size | 0.63014808 |
| 117 | MP0004084_abnormal_cardiac_muscle | 0.62974322 |
| 118 | MP0004883_abnormal_blood_vessel | 0.62884617 |
| 119 | MP0002085_abnormal_embryonic_tissue | 0.62683201 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.62529783 |
| 121 | MP0001915_intracranial_hemorrhage | 0.62079795 |
| 122 | MP0002111_abnormal_tail_morphology | 0.61748548 |
| 123 | MP0005451_abnormal_body_composition | 0.61050987 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.60124465 |
| 125 | MP0002135_abnormal_kidney_morphology | 0.59593087 |
| 126 | MP0001873_stomach_inflammation | 0.59452827 |
| 127 | MP0000566_synostosis | 0.59405054 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.57577570 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.57021002 |
| 130 | MP0001191_abnormal_skin_condition | 0.56236435 |
| 131 | MP0002697_abnormal_eye_size | 0.56166898 |
| 132 | MP0009785_altered_susceptibility_to | 0.55048404 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.54908635 |
| 134 | MP0002086_abnormal_extraembryonic_tissu | 0.54749212 |
| 135 | MP0000367_abnormal_coat/_hair | 0.54744355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 4.64798903 |
| 2 | Chronic bronchitis (HP:0004469) | 4.58151506 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.18773502 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.97920212 |
| 5 | Onycholysis (HP:0001806) | 3.85223258 |
| 6 | Alopecia of scalp (HP:0002293) | 3.67432582 |
| 7 | Deep venous thrombosis (HP:0002625) | 3.60872390 |
| 8 | Complement deficiency (HP:0004431) | 3.58236269 |
| 9 | Esophageal varix (HP:0002040) | 3.52311664 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.43686908 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.39839256 |
| 12 | Abnormal hair laboratory examination (HP:0003328) | 3.37337513 |
| 13 | Xanthomatosis (HP:0000991) | 3.37015374 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.30670834 |
| 15 | Abnormality of nail color (HP:0100643) | 3.29907315 |
| 16 | Hyperglycinuria (HP:0003108) | 3.27825655 |
| 17 | Gout (HP:0001997) | 3.25629421 |
| 18 | Pustule (HP:0200039) | 3.13571622 |
| 19 | Flat acetabular roof (HP:0003180) | 3.11761541 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.11558759 |
| 21 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.08688793 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.06830547 |
| 23 | Thick nail (HP:0001805) | 3.05343058 |
| 24 | Hydroxyprolinuria (HP:0003080) | 2.94463188 |
| 25 | Abnormality of proline metabolism (HP:0010907) | 2.94463188 |
| 26 | Hyperglycinemia (HP:0002154) | 2.93794121 |
| 27 | Hyperammonemia (HP:0001987) | 2.93195635 |
| 28 | Plantar hyperkeratosis (HP:0007556) | 2.90257867 |
| 29 | Abnormality of the salivary glands (HP:0010286) | 2.84845506 |
| 30 | Glomerulonephritis (HP:0000099) | 2.75841055 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.75599595 |
| 32 | Vascular calcification (HP:0004934) | 2.74889259 |
| 33 | Milia (HP:0001056) | 2.73096786 |
| 34 | Fragile nails (HP:0001808) | 2.72918354 |
| 35 | Lip pit (HP:0100267) | 2.71523463 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.70157860 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 2.68472484 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.68472484 |
| 39 | Curly hair (HP:0002212) | 2.68213889 |
| 40 | Polycythemia (HP:0001901) | 2.65424455 |
| 41 | Abnormality of complement system (HP:0005339) | 2.61270552 |
| 42 | Rhinitis (HP:0012384) | 2.57954034 |
| 43 | Fat malabsorption (HP:0002630) | 2.57223569 |
| 44 | Malnutrition (HP:0004395) | 2.54552283 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.52411461 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.51958532 |
| 47 | Hyperlipoproteinemia (HP:0010980) | 2.51913528 |
| 48 | Abnormality of permanent molar morphology (HP:0011071) | 2.49212758 |
| 49 | Abnormality of the dental root (HP:0006486) | 2.49212758 |
| 50 | Taurodontia (HP:0000679) | 2.49212758 |
| 51 | Bronchiectasis (HP:0002110) | 2.47608136 |
| 52 | Hematochezia (HP:0002573) | 2.46585196 |
| 53 | Ankyloglossia (HP:0010296) | 2.46004335 |
| 54 | Selective tooth agenesis (HP:0001592) | 2.43387698 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.42913186 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.41819123 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41563069 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.40563776 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.40450978 |
| 60 | Cheilitis (HP:0100825) | 2.40156371 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38710531 |
| 62 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.34519612 |
| 63 | Nephritis (HP:0000123) | 2.33679778 |
| 64 | Woolly hair (HP:0002224) | 2.31410526 |
| 65 | Premature loss of primary teeth (HP:0006323) | 2.31253973 |
| 66 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.29739560 |
| 67 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.29739560 |
| 68 | Hypoplasia of dental enamel (HP:0006297) | 2.26759333 |
| 69 | Abnormality of the dental pulp (HP:0006479) | 2.26533015 |
| 70 | Nausea (HP:0002018) | 2.23568826 |
| 71 | Absent eyelashes (HP:0000561) | 2.20754733 |
| 72 | Amelogenesis imperfecta (HP:0000705) | 2.19999909 |
| 73 | Hyperglycemia (HP:0003074) | 2.17301108 |
| 74 | Hyperuricemia (HP:0002149) | 2.16588397 |
| 75 | Increased purine levels (HP:0004368) | 2.16588397 |
| 76 | Atrophic scars (HP:0001075) | 2.15441832 |
| 77 | Hyperactive renin-angiotensin system (HP:0000841) | 2.14353895 |
| 78 | Abnormality of molar (HP:0011077) | 2.13864659 |
| 79 | Abnormality of molar morphology (HP:0011070) | 2.13864659 |
| 80 | Absent/shortened dynein arms (HP:0200106) | 2.13600393 |
| 81 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.13600393 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 2.13331599 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11966970 |
| 84 | Advanced eruption of teeth (HP:0006288) | 2.11620598 |
| 85 | Myocardial infarction (HP:0001658) | 2.11455962 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.11380512 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11380512 |
| 88 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.11308669 |
| 89 | Joint hemorrhage (HP:0005261) | 2.11220972 |
| 90 | Menorrhagia (HP:0000132) | 2.10223022 |
| 91 | Nail dystrophy (HP:0008404) | 2.09705645 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.09703846 |
| 93 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08797420 |
| 94 | Abnormal blistering of the skin (HP:0008066) | 2.07426180 |
| 95 | Abnormal ciliary motility (HP:0012262) | 2.07378530 |
| 96 | Abnormality of chloride homeostasis (HP:0011422) | 2.06862839 |
| 97 | Polygenic inheritance (HP:0010982) | 2.05994623 |
| 98 | Nasal polyposis (HP:0100582) | 2.05806694 |
| 99 | Ventricular tachycardia (HP:0004756) | 2.03678051 |
| 100 | Palmoplantar hyperkeratosis (HP:0000972) | 2.03318303 |
| 101 | Unilateral renal agenesis (HP:0000122) | 2.02465850 |
| 102 | Eczematoid dermatitis (HP:0000976) | 2.02025557 |
| 103 | Rickets (HP:0002748) | 2.01961494 |
| 104 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99627643 |
| 105 | Osteolytic defects of the hand bones (HP:0009699) | 1.99627643 |
| 106 | Biliary tract neoplasm (HP:0100574) | 1.98646259 |
| 107 | Pili torti (HP:0003777) | 1.97551236 |
| 108 | Glomerulosclerosis (HP:0000096) | 1.96700032 |
| 109 | Steatorrhea (HP:0002570) | 1.95747667 |
| 110 | Bronchitis (HP:0012387) | 1.94746572 |
| 111 | Ketosis (HP:0001946) | 1.92282300 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 1.91610119 |
| 113 | Palmar hyperkeratosis (HP:0010765) | 1.91516978 |
| 114 | Ileus (HP:0002595) | 1.91478080 |
| 115 | Hypoplastic labia majora (HP:0000059) | 1.91101008 |
| 116 | Abnormality of the nasal mucosa (HP:0000433) | 1.90297599 |
| 117 | Hypotrichosis (HP:0001006) | 1.90233394 |
| 118 | Hypercholesterolemia (HP:0003124) | 1.89057762 |
| 119 | Pterygium (HP:0001059) | 1.88484060 |
| 120 | Vacuolated lymphocytes (HP:0001922) | 1.87698367 |
| 121 | Micronodular cirrhosis (HP:0001413) | 1.86625762 |
| 122 | Epidermoid cyst (HP:0200040) | 1.86461163 |
| 123 | Spastic diplegia (HP:0001264) | 1.85868960 |
| 124 | Proximal tubulopathy (HP:0000114) | 1.85037246 |
| 125 | Abdominal distention (HP:0003270) | 1.84562084 |
| 126 | Hepatocellular carcinoma (HP:0001402) | 1.84521345 |
| 127 | Abnormality of the lacrimal duct (HP:0011481) | 1.84444157 |
| 128 | Hypoglycemic seizures (HP:0002173) | 1.84345353 |
| 129 | Tetraparesis (HP:0002273) | 1.83934119 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 1.83870931 |
| 131 | Congenital, generalized hypertrichosis (HP:0004540) | 1.82898996 |
| 132 | Abnormality of the gastric mucosa (HP:0004295) | 1.82693048 |
| 133 | Symptomatic seizures (HP:0011145) | 1.82021031 |
| 134 | Ridged nail (HP:0001807) | 1.81714427 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81641224 |
| 136 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81084773 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80398353 |
| 138 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79973549 |
| 139 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79598166 |
| 140 | Sparse eyelashes (HP:0000653) | 1.79591092 |
| 141 | Generalized aminoaciduria (HP:0002909) | 1.77693032 |
| 142 | Aortic aneurysm (HP:0004942) | 1.77421330 |
| 143 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.77019609 |
| 144 | Hemorrhage of the eye (HP:0011885) | 1.76720109 |
| 145 | Abnormality of oral frenula (HP:0000190) | 1.76691984 |
| 146 | Blepharitis (HP:0000498) | 1.76364066 |
| 147 | Cerebral aneurysm (HP:0004944) | 1.75953453 |
| 148 | Abnormal hemoglobin (HP:0011902) | 1.75657074 |
| 149 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.75624383 |
| 150 | Gastrointestinal carcinoma (HP:0002672) | 1.75624383 |
| 151 | Bronchomalacia (HP:0002780) | 1.74978573 |
| 152 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.74805892 |
| 153 | Abnormality of macrophages (HP:0004311) | 1.74049150 |
| 154 | Absent eyebrow (HP:0002223) | 1.73761958 |
| 155 | Palpitations (HP:0001962) | 1.72526081 |
| 156 | Renal salt wasting (HP:0000127) | 1.72199762 |
| 157 | Neonatal death (HP:0003811) | 1.71900254 |
| 158 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.71598975 |
| 159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71211813 |
| 160 | Abnormal vertebral ossification (HP:0100569) | 1.70408767 |
| 161 | Uterine neoplasm (HP:0010784) | 1.68575242 |
| 162 | Popliteal pterygium (HP:0009756) | 1.68157606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 6.29486119 |
| 2 | TGFBR2 | 3.94120455 |
| 3 | TIE1 | 3.16763392 |
| 4 | SMG1 | 2.94917329 |
| 5 | ERN1 | 2.84937979 |
| 6 | MAP3K3 | 2.67869766 |
| 7 | BCKDK | 2.58247665 |
| 8 | KDR | 2.37236472 |
| 9 | EEF2K | 2.19294889 |
| 10 | SIK1 | 2.16510857 |
| 11 | PBK | 2.12808538 |
| 12 | MAPK15 | 2.09417845 |
| 13 | PAK4 | 2.08627127 |
| 14 | LATS1 | 2.06546600 |
| 15 | PDK2 | 1.88898060 |
| 16 | MAP2K2 | 1.84406741 |
| 17 | MST4 | 1.81116226 |
| 18 | MAP2K3 | 1.78705295 |
| 19 | FGFR4 | 1.77744128 |
| 20 | TGFBR1 | 1.75990635 |
| 21 | PTK6 | 1.73523647 |
| 22 | MST1R | 1.72947571 |
| 23 | BMX | 1.70019676 |
| 24 | CDK12 | 1.58945406 |
| 25 | STK38L | 1.56229505 |
| 26 | FRK | 1.50145779 |
| 27 | FER | 1.49839167 |
| 28 | RPS6KB2 | 1.49409754 |
| 29 | NME1 | 1.47008002 |
| 30 | EPHB2 | 1.46565643 |
| 31 | IRAK3 | 1.43968174 |
| 32 | STK10 | 1.37139850 |
| 33 | RIPK1 | 1.33018461 |
| 34 | NEK9 | 1.24405479 |
| 35 | AKT3 | 1.23688570 |
| 36 | MYLK | 1.20274938 |
| 37 | LATS2 | 1.17877122 |
| 38 | PKN2 | 1.11291431 |
| 39 | MAP3K10 | 1.11084147 |
| 40 | PTK2 | 1.10274802 |
| 41 | RPS6KA4 | 1.08476090 |
| 42 | YES1 | 1.07993025 |
| 43 | STK3 | 1.06937760 |
| 44 | TYK2 | 1.05036238 |
| 45 | FGR | 1.04235197 |
| 46 | TRIB3 | 1.00946505 |
| 47 | EPHB1 | 1.00570583 |
| 48 | MAP3K12 | 0.96705332 |
| 49 | MAPKAPK3 | 0.96455888 |
| 50 | TSSK6 | 0.95907806 |
| 51 | MAP3K9 | 0.94044373 |
| 52 | FGFR3 | 0.92771289 |
| 53 | ACVR1B | 0.92743599 |
| 54 | SIK3 | 0.91405792 |
| 55 | MET | 0.88450583 |
| 56 | MAP3K14 | 0.87516672 |
| 57 | TBK1 | 0.85344336 |
| 58 | OXSR1 | 0.84492798 |
| 59 | TESK1 | 0.83374949 |
| 60 | MAP3K1 | 0.82724668 |
| 61 | RIPK4 | 0.81491049 |
| 62 | ALK | 0.80764958 |
| 63 | MAP3K2 | 0.75470440 |
| 64 | CHUK | 0.75217947 |
| 65 | BUB1 | 0.74864727 |
| 66 | CDK6 | 0.74639281 |
| 67 | MAP2K1 | 0.74295873 |
| 68 | PRPF4B | 0.73634442 |
| 69 | GRK1 | 0.72043787 |
| 70 | FGFR1 | 0.71447415 |
| 71 | MAP2K6 | 0.71275065 |
| 72 | MAP3K11 | 0.71165533 |
| 73 | TAOK1 | 0.71138768 |
| 74 | LRRK2 | 0.70673761 |
| 75 | MARK3 | 0.69283971 |
| 76 | MATK | 0.68298271 |
| 77 | FLT3 | 0.67032147 |
| 78 | PIK3CA | 0.66062781 |
| 79 | NUAK1 | 0.62988838 |
| 80 | MAP3K6 | 0.62899721 |
| 81 | PRKG2 | 0.62810469 |
| 82 | ICK | 0.62002782 |
| 83 | PIM2 | 0.59186579 |
| 84 | INSRR | 0.58977893 |
| 85 | STK24 | 0.58461446 |
| 86 | NEK6 | 0.56115733 |
| 87 | ZAP70 | 0.55922724 |
| 88 | ERBB2 | 0.55745311 |
| 89 | MAP3K8 | 0.55517651 |
| 90 | GRK7 | 0.54718649 |
| 91 | MAP3K13 | 0.53725992 |
| 92 | WEE1 | 0.53009411 |
| 93 | IKBKB | 0.52062787 |
| 94 | LMTK2 | 0.51000908 |
| 95 | STK39 | 0.50987177 |
| 96 | ZAK | 0.50950640 |
| 97 | TAOK3 | 0.50734293 |
| 98 | PIK3CG | 0.48348659 |
| 99 | MTOR | 0.47880699 |
| 100 | PRKAA2 | 0.47590598 |
| 101 | EPHA3 | 0.46705244 |
| 102 | CDC42BPA | 0.46507074 |
| 103 | GRK6 | 0.46150034 |
| 104 | SRPK1 | 0.45399512 |
| 105 | PDGFRA | 0.45294510 |
| 106 | DYRK1B | 0.45012594 |
| 107 | DYRK3 | 0.44419486 |
| 108 | NLK | 0.43756009 |
| 109 | TESK2 | 0.43357982 |
| 110 | CSK | 0.43224998 |
| 111 | EGFR | 0.43222574 |
| 112 | PAK2 | 0.42708359 |
| 113 | GSK3A | 0.42693465 |
| 114 | EIF2AK1 | 0.41252479 |
| 115 | PDPK1 | 0.41141509 |
| 116 | PRKCI | 0.40859669 |
| 117 | CAMK1D | 0.40611523 |
| 118 | TAF1 | 0.40153897 |
| 119 | TTK | 0.37327886 |
| 120 | MAPK11 | 0.37268463 |
| 121 | RET | 0.37197881 |
| 122 | FGFR2 | 0.37168518 |
| 123 | CDK7 | 0.37047382 |
| 124 | JAK2 | 0.35959882 |
| 125 | KSR2 | 0.35744174 |
| 126 | MAPKAPK2 | 0.35526469 |
| 127 | TTN | 0.34739947 |
| 128 | DMPK | 0.34551439 |
| 129 | ERBB4 | 0.32958712 |
| 130 | BRSK2 | 0.32232397 |
| 131 | BMPR1B | 0.32028959 |
| 132 | IRAK1 | 0.31769720 |
| 133 | AURKB | 0.30581102 |
| 134 | JAK3 | 0.30530574 |
| 135 | CDK4 | 0.30079654 |
| 136 | STK4 | 0.30043300 |
| 137 | RPS6KA2 | 0.30020007 |
| 138 | BRD4 | 0.28390610 |
| 139 | EIF2AK2 | 0.28176240 |
| 140 | IKBKE | 0.27952272 |
| 141 | NME2 | 0.26797049 |
| 142 | IGF1R | 0.26484019 |
| 143 | JAK1 | 0.26274939 |
| 144 | CSF1R | 0.26123727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.91007682 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58518925 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32693266 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30477166 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24265377 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12679936 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.12652578 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12163267 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06033085 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.05443888 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04401972 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01293258 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.99285825 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97881583 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93360374 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92491701 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89371001 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.82459628 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80560444 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.80025954 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78168085 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77612112 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.75882561 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66769931 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64042716 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63883718 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.56510133 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49463569 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46021725 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45284165 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43678607 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.37594832 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32008086 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31726513 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.30758929 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29614930 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25436320 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23842066 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18883044 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17223115 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14305235 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11710327 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.08570890 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07010814 |
| 45 | Mineral absorption_Homo sapiens_hsa04978 | 1.06590316 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06458273 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00896398 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00506832 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.99383522 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.98840401 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97060571 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96431215 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91597412 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91215186 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85093370 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83622654 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82795211 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80398171 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80377578 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80343024 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79224079 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78865505 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78633538 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76862314 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.75289620 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74906665 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73019806 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.72792341 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72013587 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71235964 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70968986 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70774305 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70752130 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70052654 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69905313 |
| 76 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69435482 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68373998 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66740801 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65916746 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63831323 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62679789 |
| 82 | * Tight junction_Homo sapiens_hsa04530 | 0.59414349 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58130102 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58075684 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57509799 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56169215 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55315972 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55283674 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.55048631 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54437063 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54046667 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.52485142 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52383913 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51971331 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51545041 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51366079 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49993040 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49552735 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49124412 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48791294 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.46587532 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.45223104 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44148640 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44106391 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.43906029 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.42798389 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.42687821 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42326249 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.41981451 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41694172 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41373997 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40746358 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38469743 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.37673634 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37614351 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36518627 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.36492307 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36076084 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35908824 |
| 120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34778700 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33415487 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.30644162 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29990107 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.29297973 |

